key: cord-0863991-p99thqgt
authors: Fu, Jianhong; Kong, Jindan; Wang, Wei; Wu, Meiying; Yao, Lin; Wang, Zhaoyue; Jin, Jun; Wu, Depei; Yu, Xin
title: The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China
date: 2020-05-06
journal: Thromb Res
DOI: 10.1016/j.thromres.2020.05.006
sha: 7400110e77de9824ff53797dfade054fa9a9cf80
doc_id: 863991
cord_uid: p99thqgt

Abstract Objective To investigate the clinical features of COVID-19 cases in Suzhou China. Biomarkers were screened out of hematological parameters for risk stratification. Method Confirmed COVID-19 adult patients in Suzhou were included. The patient data was collected, and the results of laboratory examinations were compared between the mild/moderate and severe COVID-19 groups. A ROC was calculated to compare the diagnostic performance of candidate indexes, and dynamic levels of hematological indexes were compared between the two groups. Result 75 patients were enrolled, with a mean age of 46.6 ± 14 years, and 45 patients were male. All patients were classified into two groups: the mild/moderate group and the severe group. WBC, neutrophil to lymphocyte ratio (NLR), D-dimer, and fibrinogen levels of the severe group were significantly higher (P < 0.05) than the mild/moderate, and the lymphocyte was lower. The ROC test showed that the hematological parameters had a larger AUC than that of inflammatory factors. There was a significant difference in lymphocyte and fibrinogen levels between the two groups on day 1 (P < 0.05). However, NLR of the severe group was higher than the mild/moderate on days 1, 4 and 14 (P < 0.01), and so was D-dimer on days 1, 7 and 14 (P < 0.05). Conclusion The common COVID-19 abnormal hematological indexes on admission included hyperfibrinogenemia, lymphopenia, the elevation of D-dimer, and leukopenia, which were significantly different between the mild/moderate and severe COVID-19 groups. Furthermore, the dynamic change of NLR and D-dimer level can distinguish severe COVID-19 cases from the mild/moderate.

Since December 2019, an outbreak of cluster pneumonia of unknown cause happened in Wuhan, the capital city of Central China province, Hubei [1, 2] .

Subsequently, a novel coronavirus was isolated from patient groups in Wuhan and soon identified to be the causative pathogen of this highly contagious pneumonia [3, 4] . In February 2020, the World Health Organization formally designated the disease COVID-19 (coronavirus disease 2019), and the novel coronavirus was designated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In two months, the outbreak of COVID-19 spread from Wuhan to all other districts of China.

SARS-CoV-2 also caused many hospital transmissions and more than three thousand Chinese health workers were infected until March 15, 2020 [5] . On January 26, Wuhan city was locked down in an unprecedented manner with the majority of public transport cancelled. The WHO recently announced the current situation of COVID-19 as a global pandemic. Up to now there are no available specific curative medicines and vaccines, and the treatment methods for COVID-19 are largely supportive.

Several abnormal hematological parameters were reported in COVID-19 patients [6-9], including lymphopenia, neutrophilia, elevated levels of D-dimer and fibrinogen, but the clinical implication of these indexes remains elusive. The neutrophil to lymphocyte ratio (NLR) is a convenient index that can be calculated from a complete J o u r n a l P r e -p r o o f blood count, and many studies showed that NLR had a prognostic value in various conditions, including sepsis, cardiovascular diseases, and malignant tumors, etc. [10] [11] [12] [13] . Increased thrombogenicity and higher platelet aggregation had been proven in community acquired pneumonia, and a recent study reported that COVID-19 can induce a massive prothrombotic status [14-15]. D-dimer was also found to correlate with the prognosis of 2009 novel influenza A (H1N1) pneumonia [16] . Herein we performed a retrospective study of COVID-19 patients in the designated hospital in Suzhou China, and the correlation between hematological parameters and different severity groups of COVID-19 was analyzed.

Consecutive adult patients (≥18 years old) with a confirmed diagnosis of COVID-19 admitted to the Affiliated Infectious Diseases Hospital of Soochow University from January 20 to February 20, 2020, were enrolled in this retrospective study. Many senior doctors from other medical centers in Suzhou were sent to this hospital to care COVID-19 patients. The diagnosis and classification of COVID-19 were based on the trial version 1-5 guidelines on the novel coronavirus-infected pneumonia diagnosis and treatment (issued by the National Health Commission of China). All patients were followed up till March 10. The study was approved by the hospital's Ethics Committee and the written informed consent was obtained from patients enrolled.

According to the severity of COVID-19, all patients were classified into two groups: the mild/moderate group, and the severe group. The mild/moderate group included J o u r n a l P r e -p r o o f mild and moderate cases. The severe group consisted of severe and critical cases which fulfilled one of these criteria as follows: 1) respiratory distress (RR ≥30 bpm);

2) oxygen saturation ≤93%; 3) arterial partial pressure of oxygen (PaO2)/fraction of inspired oxygen (FiO2)＜300 mmHg; 4) patients with chest imaging that indicates an obvious progression of infiltrations within 24-48 hours. 5) respiratory failure and requiring mechanical ventilation, shock or other organ failure need ICU support. was used for data analysis. All data are presented as means ± SD or median (range).

Independent sample t-tests and chi-square tests were used to compare the differences between the two groups. The receiver operating curve (ROC) and the area under the curve (AUC) were calculated to compare the diagnostic performance of each parameter. A value of p < 0.05 was considered statistically significant.

In this retrospective study, 75 confirmed COVID-19 patients were included until February 20, 2020. The mean age of patients was 46.6±14 (22-77) years, and 45 patients (60%) were male ( Table 1 ). The epidemiological survey found that 41 patients (54.7%) had a history of Hubei travel or residency. The common clinical manifestations of COVID-19 at admission were fever (62, 86.7%), cough (54, 72%) and sore throat (12, 16%), and other less common symptoms included myalgia, diarrhea, shortness of breath and rhinorrhea. Thirteen patients had underlying chronic diseases, including seven with hypertension, four with chronic respiratory disease, four with diabetes mellitus, and one with malignant tumor history. The median period from onset to admission was 5.6±3.5 days (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) . Sixteen patients were classified into the severe group and admitted to the special ICU ward, and 59 patients were classified into the mild/moderate group and admitted to the normal isolation ward. Most patients were reported with bilateral pneumonia proved by chest CT, and 84% positive findings of CT were characterized as multiple mottling and ground-grass opacity. Figure 1 showed the representative pulmonary CT of two COVID-19 patients.

On admission, obvious abnormalities of laboratory blood examinations were found, especially for peripheral blood cell analysis and coagulation profile ( Table 2) .

Hemocytopenia was common, including lymphopenia, leukopenia, and thrombocytopenia (45.3%, 21.3%, and 12%, respectively). The rate of anemia was 8%. The neutrophil-to-lymphocyte ratio was 2. The demographic and hematological parameters on admission were compared between patients in the mild/moderate and severe groups (Table 3 ). There was no statistical difference in age, gender, days from onset to admission and hemoglobin level between the two groups. However, compared to the mild/moderate COVID-19 group, WBC, NLR, D-dimer, and fibrinogen levels of severe group were significantly higher (P＜0.05), and the lymphocyte level was lower (P＜0.01). The ROC and AUC of hematological and inflammatory indexes were calculated between the two groups ( Figure 2 ). Of the six indexes, the highest AUC is NLR (0.88), and the AUC of D-dimer and fibrinogen was 0.74, and those of lymphocyte and PCT were 0.72 and 0.67 respectively. Four hematological indexes (lymphocyte, NLR, fibrinogen, and D-dimer) were compared between the two groups on different hospitalization days.

As seen in Figure 3 , lymphocyte and fibrinogen levels between the two groups had a significant difference on day 1 (P＜0.05), but the difference disappeared over time.

However, NLR distinguished the severe COVID-19 cases from the mild/moderate on days 1, 4 and 14 (P＜0.01), and so did D-dimer on days 1, 7 and 14 (P＜0.05).

From the beginning of COVID-19 outbreak, Wuhan and surrounding districts of The common symptoms of Suzhou COVID-19 cohort were fever (82.7%), cough (73.1%) and sore throat (26%), 13% of patients had an underlying medical chronic illness. 76% of patients with a bilateral ground-glass opacity on CT. In our study, 16 patients (21.3%) were classified as severe cases and admitted to ICU. Of them, seven received HFNC while four received NIV therapy and no patient died. This is in agreement with early studies that most COVID-19 cases had a mild clinical course and recovered in two weeks with supportive therapy, but the rest 15%-20% cases will Our study aimed to find meaningful COVID-19 biomarkers out of conventional hematological examinations for disease severity classification and early warning of J o u r n a l P r e -p r o o f progression. We compared the level of inflammatory factors and hematological parameters between two different groups of disease severity (Table 3) , and six candidate indexes (CRP, PCT, lymphocyte, NLR, fibrinogen, and D-dimer) were chosen for ROC test. As seen in Figure 2 , the hematological parameters had a higher Two main limitations must be acknowledged. First, as a retrospective cohort study in a single center, there were only 75 COVID-19 patients included and most of them were exported cases. A multiple-center, prospective research is needed to further clarify the value of D-dimer and NLR in COVID-19. Second, we did not test cytokines like interleukin-2 receptor (IL-2R) and interleukin-6 (IL-6) because of a shortage of biosafety labs. However, the benefit of routine cytokines monitor is still of controversy. We believed that ideal biomarkers for COVID-19 should be easily accessible, inexpensive and correct. Tests or techniques that incur unnecessary exposure need careful consideration of risk and benefit.

In summary, our results indicated that the epidemiological and clinical feature of COVID-19 cases in Suzhou is similar to previous reports. The common abnormalities J o u r n a l P r e -p r o o f in hematological parameters in COVID-19 patients included hyperfibrinogenemia (60%), lymphocytopenia (45.3%), leukopenia (21.3%), while thrombocytopenia (12%) and anemia (8%) was less common. There was a significant difference concerning four hematological parameters and CRP between the mild/moderate and severe COVID-19 groups. The dynamic change of neutrophil to lymphocyte ratio (NLR) and D-dimer level can discriminate severe COVID-19 cases from mild/moderate ones on consequent days after admission.

J o u r n a l P r e -p r o o f (1, 4, 7, 14) between the mild/moderate and severe patient group. B. Neutrophil-to-lymphocyte ratio (NLR) on four different days (1, 4, 7, 14) between the mild/moderate and severe patient group. C. Fibrinogen level on three different days (1, 7, 14) between the mild/moderate and severe patient group. D. D-dimer level on three different days (1, 7, 14) between the mild/moderate and severe patient group.

J o u r n a l P r e -p r o o f J o u r n a l P r e -p r o o f J o u r n a l P r e -p r o o f 

A Novel Coronavirus from Patients with Pneumonia in China

Pandemic potential of 2019-nCoV

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. NEW ENGL J MED 2020. 5

Hematologic parameters in patients with COVID-19 infection

The utility of peripheral blood leucocyte ratios as biomarkers in infectious diseases: A systematic review and meta-analysis

Reference Values for Neutrophil to Lymphocyte Ratio (NLR), a Biomarker of Cardiovascular Risk, According to Age and Sex in a Latin American Population

Importance of prognostic value of neutrophil to lymphocyte ratio in patients with ST-elevation myocardial infarction

Prognostic role of pretreatment blood neutrophil-to-lymphocyte ratio in advanced cancer survivors: A systematic review and meta-analysis of 66 cohort studies